Insider activity (SEC Form 4)
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
Open-market · last 30 days:
0 buyers bought $0
8 sellers sold $75.6M
Open-market · last 90 days:
0 buyers bought $0
8 sellers sold $77.8M
| Insider | Role | Date | Transaction | Shares | Value |
| Goldwasser Lesley |
Director |
2026-11-05 |
Grant/award |
280 |
$113K |
| OLIVO MARIA |
EVP, ERM & Chief Risk Officer |
2026-11-04 |
Open-market sell |
15000 |
$6.1M |
| BESSETTE ANDY F |
EVP and Chief Admin Officer |
2026-10-28 |
Open-market sell |
3000 |
$1.2M |
| BESSETTE ANDY F |
EVP and Chief Admin Officer |
2026-10-28 |
Gift |
25 |
$0 |
| Lefebvre Mojgan M |
EVP & Chief Tech & Ops Officer |
2026-10-27 |
Option exercise |
11000 |
$1.5M |
| Lefebvre Mojgan M |
EVP & Chief Tech & Ops Officer |
2026-10-27 |
Open-market sell |
11000 |
$4.3M |
| Klenk Jeffrey P. |
EVP & Pres., Bond & Spec. Ins. |
2026-10-22 |
Option exercise |
9016 |
$1.2M |
| Klenk Jeffrey P. |
EVP & Pres., Bond & Spec. Ins. |
2026-10-22 |
Open-market sell |
9016 |
$3.7M |
| Rowland David Donnay |
EVP & Co-Chief Invest. Officer |
2026-10-22 |
Option exercise |
5000 |
$663K |
| Rowland David Donnay |
EVP & Co-Chief Invest. Officer |
2026-10-22 |
Open-market sell |
5000 |
$2.0M |
| Toczydlowski Gregory C |
EVP & President, Business Ins. |
2026-10-22 |
Option exercise |
34771 |
$4.9M |
| Toczydlowski Gregory C |
EVP & President, Business Ins. |
2026-10-22 |
Open-market sell |
32671 |
$13.2M |
| Toczydlowski Gregory C |
EVP & President, Business Ins. |
2026-10-22 |
Open-market sell |
2100 |
$849K |
| OLIVO MARIA |
EVP, ERM & Chief Risk Officer |
2026-10-21 |
Open-market sell |
15100 |
$6.0M |
| Schnitzer Alan D |
Chairman and CEO, Director |
2026-10-21 |
Option exercise |
298368 |
$39.6M |
| Schnitzer Alan D |
Chairman and CEO, Director |
2026-10-21 |
Tax withholding |
209468 |
$83.3M |
| Schnitzer Alan D |
Chairman and CEO, Director |
2026-10-21 |
Open-market sell |
12901 |
$5.1M |
| Schnitzer Alan D |
Chairman and CEO, Director |
2026-10-21 |
Open-market sell |
12369 |
$4.9M |
| Schnitzer Alan D |
Chairman and CEO, Director |
2026-10-21 |
Open-market sell |
15759 |
$6.3M |
| Schnitzer Alan D |
Chairman and CEO, Director |
2026-10-21 |
Open-market sell |
44879 |
$17.8M |
Most recent 20 reported transactions. Open-market buys (P) and sells (S) are the deliberate ones; grants and option exercises are compensation. Not investment advice.
8-K
filed 2026-08-07
confidence 95%
Item 5.02
The disclosure centers on the election of Anthony Jabbour as a director effective August 5, 2026, with appointment to the Audit and Risk Committees. While the section also mentions compensation arrangements, the principal action disclosed is the appointment of a new director to the board, making this an exec_appointment event. The appointment of an experienced executive (former CEO of Dun & Bradstreet and Black Knight) to a major insurer's board is material to investors.
View raw filing on EDGAR →
8-K
filed 2026-07-24
confidence 95%
Item 8.01
The Company entered into an Underwriting Agreement on July 21, 2026 for the issuance and sale of $750,000,000 aggregate principal amount of 4.950% Senior Notes due 2031. This is a material creation of a direct financial obligation through debt issuance, disclosed under Item 8.01 (Other Events) with the underwriting agreement attached as an exhibit. The $750 million principal amount and senior note status make this a material capital event for a reasonable investor.
View raw filing on EDGAR →
8-K
filed 2026-07-17
confidence 99%
Item 2.02
The Company issued a press release on July 17, 2026 announcing second quarter and year-to-date 2026 financial results, including net income of $2.208 billion ($10.26 per diluted share) for Q2 2026 and core income of $2.160 billion ($10.04 per diluted share). The disclosure includes detailed consolidated and segment financial metrics, combined ratios, underwriting performance, and capital allocation activities. This is a standard quarterly earnings release furnished as Exhibit 99.1, typical of Item 2.02 disclosures.
View raw filing on EDGAR →
8-K
filed 2026-05-22
confidence 99%
Item 5.07
Travelers Companies held its annual meeting of shareholders on May 20, 2026, and disclosed the voting results for six items: election of eight directors, ratification of the independent auditor, non-binding executive compensation vote, amendment to the 2023 Stock Incentive Plan increasing authorized shares by 5,000,000, and two shareholder proposals.
View raw filing on EDGAR →
8-K
filed 2026-05-21
confidence 72%
Item 8.01
The Company entered into a new $1.2 billion Five-Year Revolving Credit Agreement on May 15, 2026, replacing a prior $1.0 billion facility. While this represents a material refinancing and increase in available liquidity, it does not fit neatly into the more specific event categories (ma_activity applies to acquisitions/dispositions, not credit facility amendments; covenant_breach applies to violations, not new covenant establishment). The disclosure is material to investors as it affects the Company's financial flexibility and capital structure, but the event is best classified as other_material given the absence of a dedicated taxonomy entry for credit facility amendments or refinancings.
View raw filing on EDGAR →